Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant.

E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant. Abstract Text:

    sally t ishizakaSally T Ishizaka,lynn d hawkinsLynn D Hawkins,sally t ishizakaSally T Ishizaka,lynn d hawkinsLynn D Hawkins,

    Safe and cost-effective adjuvants are a critical component to enhance the efficacy of subunit vaccines. Studies have demonstrated that modified natural lipid As derived from enterobacterial lipopolysaccharides, which are agonists of Toll-like receptor 4, are beneficial to vaccine performance. The synthetic phospholipid dimer, E6020, mimics the physicochemical and biological properties of many of the natural lipid As derived from gram-negative bacteria. Similar to its natural counterparts, E6020, which was discovered and developed by Eisai, agonizes Toll-like receptor 4, albeit in an attenuated fashion, eliciting an immunostimulatory response that is conducive to use as a vaccine adjuvant. The derivation of E6020, along with physicochemical properties and in vitro and in vivo studies of immunostimulation and adjuvant activity, are reviewed as a background to its imminent assessment in the clinic.

    E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant. Publishing Authors By Initials

    st ishizakaST Ishizaka,ld hawkinsLD Hawkins,st ishizakaST Ishizaka,ld hawkinsLD Hawkins,

    For similar complex mixtures: biological products: vaccines research abstracts see: complex mixtures: biological products: vaccines research

    PUBMED ID PMID:

    MEDLINE DATE:

    E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant. Journal Published:

    PUBLICATION TYPE: Review

    Journal: Expert review of vaccines

    VOLUME: 6

    Page Numbers: 773-84

    Journal Abbreviation:

    ISSN: 1744-8395

    DAY: 28

    MONTH: Oct

    YEAR: 2007

    E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 101155475

    E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant. Keywords Mesh Terms:

    KEYWORDS: Vaccines

    MESH TERMS: chemistry

    Chemical & Substance for Abstract: E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant. Information

    Substance Name: Vaccines

    Registry Number: 0

    Grant and Affiliation Information for E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant.

    AFFILIATION: Eisai Research Institute, 4 Corporate Drive, Andover, MA 01742, USA. sally_ishizaka@eri.eisai.com

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Expert Rev Vaccines

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    E6020: a synthetic Toll-like receptor 4 agonist as a vaccine adjuvant Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News